Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Faccioli

Showing results (41-50 of 369) with videos related to

Pageof 37
Sort By:
Seminars in Liver Disease|August 31, 2022
From a Single Cell to a Whole Human Liver: Disease Modeling and TransplantationTakashi Motomura, Lanuza A P Faccioli, Ricardo Diaz-Aragon, et al.
International Journal of Molecular Sciences|September 9, 2023
Evaluation of Human Hepatocyte Drug Metabolism Carrying High-Risk or Protection-Associated Liver Disease Genetic VariantsLanuza A P Faccioli, Zeliha Cetin, Zehra N Kocas-Kilicarslan, et al.
Iscience|November 21, 2022
Biofabrication of synthetic human liver tissue with advanced programmable functionsRodrigo M Florentino, Kazutoyo Morita, Nils Haep, et al.
Frontiers in Cell and Developmental Biology|September 26, 2024
Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapyMengying Xia, Mahboubeh Varmazyad, Iris Pla-Palacín, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Comparison of Wild-Type and High-risk PNPLA3 variants in a Human Biomimetic Liver Microphysiology System for Metabolic Dysfunction-associated Steatotic Liver Disease Precision TherapyMengying Xia, Maboubeh Varmazyad, Iris Pla Palacin, et al.
Critical Care Medicine|March 18, 2014
Effects of bone marrow-derived mononuclear cells from healthy or acute respiratory distress syndrome donors on recipient lung-injured miceJohnatas D Silva, Bruno D Paredes, Indianara M Araújo, et al.
Stem Cells International|July 17, 2024
Safety and Biodistribution of an Autologous Bone Marrow-Derived Mononuclear Cell Infusion into Renal Arteries in Patients with Focal Segmental Glomerulosclerosis: A Phase 1 StudyBruno Freire Botelho, André Luis Barreira, Marcio Gomes Filippo, et al.
Gastro Hep Advances|January 31, 2024
Polymorphisms Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Influence the Progression of End-Stage Liver DiseaseZehra N Kocas-Kilicarslan, Zeliha Cetin, Lanuza A P Faccioli, et al.
Hepatology (Baltimore, Md.)|August 20, 2025
Human-induced pluripotent stem cell-based hepatic modeling of lipid metabolism-associated TM6SF2-E167K variantLanuza A P Faccioli, Yiyue Sun, Olamide Animasahun, et al.
Hepatology (Baltimore, Md.)|August 27, 2024
Human-induced pluripotent stem cell-based hepatic modeling of lipid metabolism-associated TM6SF2-E167K variantLanuza A P Faccioli, Yiyue Sun, Olamide Animasahun, et al.
Pageof 37

Showing results (41-50 of 369) with videos related to

Sort By:
Pageof 37
Seminars in Liver Disease|August 31, 2022
From a Single Cell to a Whole Human Liver: Disease Modeling and TransplantationTakashi Motomura, Lanuza A P Faccioli, Ricardo Diaz-Aragon, et al.
International Journal of Molecular Sciences|September 9, 2023
Evaluation of Human Hepatocyte Drug Metabolism Carrying High-Risk or Protection-Associated Liver Disease Genetic VariantsLanuza A P Faccioli, Zeliha Cetin, Zehra N Kocas-Kilicarslan, et al.
Iscience|November 21, 2022
Biofabrication of synthetic human liver tissue with advanced programmable functionsRodrigo M Florentino, Kazutoyo Morita, Nils Haep, et al.
Frontiers in Cell and Developmental Biology|September 26, 2024
Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapyMengying Xia, Mahboubeh Varmazyad, Iris Pla-Palacín, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Comparison of Wild-Type and High-risk PNPLA3 variants in a Human Biomimetic Liver Microphysiology System for Metabolic Dysfunction-associated Steatotic Liver Disease Precision TherapyMengying Xia, Maboubeh Varmazyad, Iris Pla Palacin, et al.
Critical Care Medicine|March 18, 2014
Effects of bone marrow-derived mononuclear cells from healthy or acute respiratory distress syndrome donors on recipient lung-injured miceJohnatas D Silva, Bruno D Paredes, Indianara M Araújo, et al.
Stem Cells International|July 17, 2024
Safety and Biodistribution of an Autologous Bone Marrow-Derived Mononuclear Cell Infusion into Renal Arteries in Patients with Focal Segmental Glomerulosclerosis: A Phase 1 StudyBruno Freire Botelho, André Luis Barreira, Marcio Gomes Filippo, et al.
Gastro Hep Advances|January 31, 2024
Polymorphisms Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Influence the Progression of End-Stage Liver DiseaseZehra N Kocas-Kilicarslan, Zeliha Cetin, Lanuza A P Faccioli, et al.
Hepatology (Baltimore, Md.)|August 20, 2025
Human-induced pluripotent stem cell-based hepatic modeling of lipid metabolism-associated TM6SF2-E167K variantLanuza A P Faccioli, Yiyue Sun, Olamide Animasahun, et al.
Hepatology (Baltimore, Md.)|August 27, 2024
Human-induced pluripotent stem cell-based hepatic modeling of lipid metabolism-associated TM6SF2-E167K variantLanuza A P Faccioli, Yiyue Sun, Olamide Animasahun, et al.
Pageof 37